Clinuvel Pharmaceuticals Stock
Clinuvel Pharmaceuticals Stock
There is an upward development for Clinuvel Pharmaceuticals compared to yesterday, with an increase of €0.13 (2.400%).
Our community identified positive and negative aspects for Clinuvel Pharmaceuticals stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Clinuvel Pharmaceuticals stock. On the other hand our users think that "Customer and product portfolio" could be a problem in the future.
Pros and Cons of Clinuvel Pharmaceuticals in the next few years
Pros
?
M***** P*******
?
S********** s********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Clinuvel Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Clinuvel Pharmaceuticals | 2.400% | -0.817% | -10.681% | -17.671% | -20.934% | -51.741% | -67.083% |
| Carbylan Therapeutics Inc | -2.450% | 0.000% | 0.000% | 116.574% | 81.318% | 136.263% | 40.904% |
| Pharma Mar S.A. | 0.300% | 6.226% | 4.000% | 3.540% | 8.837% | 139.474% | 18.318% |
| Mayne Pharma Group Ltd. | 0.000% | 5.455% | 16.000% | -33.588% | 7.407% | -36.957% | 994.340% |
